1
Pharmacokinetics of Omeprazole and Midazolam When Co-administered With ACT-1014-6470
Condition(s):Drug Drug Interaction; HealthyLast Updated:January 14, 2022Completed
Omeprazole: 533 Clinical Trials, Page 1 of 54
Hide Studies Not Open or Pending
2
Optimal Dosing of Omeprazole in Neonates
Condition(s):Gastroesophageal Reflux Disease (GERD)Last Updated:October 11, 2012Completed
3
High Dose Omeprazole in Patients With Pancreatic Cancer
Condition(s):Exocrine Pancreatic CancerLast Updated:November 22, 2021Recruiting
4
The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and Omeprazole
Condition(s):Prostate Cancer PatientsLast Updated:December 19, 2020Recruiting
5
Oral Omeprazole in Bleeding Peptic Ulcer
Condition(s):Bleeding Peptic UlcerLast Updated:November 25, 2019Unknown status
6
Prilosec Bioequivalence Study in Healthy Volunteers
Condition(s):Bioequivalence, AUC, Cmax, PharmacokineticsLast Updated:November 25, 2013Completed
7
Study to Compare the Bioavailability of Omeprazole 20 mg Before and After Undergoing Surgery for Morbid Obesity
Condition(s):Bariatric Surgery CandidateLast Updated:February 25, 2019Completed
8
Single Dose Omeprazole Versus High Dose in High-risk Critically Ill Patients.
Condition(s):Critical IllnessLast Updated:January 3, 2018Completed
9
Effect of Omeprazole on Metformin
Condition(s):HealthyLast Updated:March 19, 2013Completed
10
Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF)
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:November 20, 2017Completed